Skip to main content
. 2005 Mar;49(3):987–995. doi: 10.1128/AAC.49.3.987-995.2005

FIG. 7.

FIG. 7.

Development of S. aureus 133 resistance to EMAIPU (compound 1; ▪), determined as described in Material and Methods, in comparison to the development of resistance to rifampin (•) and moxifloxacin (▴).